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ABSTRACT  
 The aims of the present study in adolescents were 1) to examine how various body 
composition-screening tests relate to single and clustered cardiovascular disease (CVD) risk 
factors, 2) to examine how lean mass and body fatness (independently of each other) relate to 
clustered CVD risk factors and, 3) to calculate specific thresholds for body composition 
indices associated with an unhealthier clustered CVD risk.  We measured 1089 European 
adolescents (46.7% boys, 12.5-17.49yr) in 2006-2007. CVD risk factors included: systolic 
blood pressure, maximum oxygen uptake, homeostasis model assessment, C-reactive protein 
(n=748), total cholesterol/high density lipoprotein cholesterol and triglycerides. Body 
composition indices included: height, body mass index (BMI), lean mass, the sum of four 
skinfolds, central/peripheral skinfolds, waist circumference (WC), waist-to-height ratio 
(WHtR) and waist-to-hip ratio (WHR). Most body composition indices are associated with 
single CVD risk factors. The sum of four skinfolds, WHtR, BMI, WC and lean mass are 
strong and positively associated with clustered CVD risk. Interestingly, lean mass is 
positively associated with clustered CVD risk independently of body fatness in girls. 
Moderate and highly accurate thresholds for the sum of four skinfolds, WHtR, BMI, WC and 
lean mass are associated with an unhealthier clustered CVD risk (all AUC > 0.773).  In 
conclusion, our results support an association between most of the assessed body composition 
indices and single and clustered CVD risk factors. In addition, lean mass (independent of 
body fatness) is positively associated with clustered CVD risk in girls, which is a novel 
finding that helps to understand why an index such as BMI is a good index of CVD risk but a 
bad index of adiposity. Moderate to highly accurate thresholds for body composition indices 
associated with a healthier clustered CVD risk were found. Further studies with a longitudinal 
design are needed to confirm these findings. 
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Abbreviations and definitions in alphabetical order: 
AUC (area under the curve), BF (body fat),  BMI (body mass index), BP (blood pressure), CV 
(cardiovascular), CVD (cardiovascular disease), CRP (C-reactive protein), HC (hip 
circumference), HDLc (high-density lipoprotein cholesterol), HELENA-CSS (Healthy 
Lifestyle in Europe by Nutrition in Adolescence cross-sectional study), HOMA-IR 
(homeostasis model assessment – insulin resistance) index, LV (left ventricular), ROC 
(receiver operating characteristic), SBP (systolic blood pressure), TC (total cholesterol), 
VO2max (maximum oxygen consumption), WC (waist circumference), WHR (waist-to-hip 
ratio), WHtR (waist-to-height ratio) 
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INTRODUCTION:  
Cardiovascular (CV) diseases (CVD) usually occur during adulthood although it might have 
its origin already in childhood or adolescence
1,2
. Some body composition indices seem to 
predict CVD risk and are recommended as possible screening tools in the absence of other 
CV risk measures.  
From a methodological perspective, clustering of CVD risk factors seems to be a much 
stronger measure of CV health than single risk factors in children, as a subject with CVD risk 
may present high levels of several risk factors simultaneously 
3
. There is controversy as to 
which body composition indices are the best when screening youths and adults for cardio 
metabolic risk, with some studies suggesting the use of body mass index ( BMI) or body fat 
(BF) percentage (%) 
4
 while others suggesting waist circumference (WC) and skinfolds 
5
.  
Most research to date has focused in finding an association between CVD risk factors and 
adiposity. However, little research has included lean mass (independent of BF) as a possible 
body composition index associated with single CVD risk factors 
6
 and no one has focused on 
understanding the association between lean mass and clustered CVD risk factors. Recently, 
several lines of evidence have also implicated chronic inflammation in CVD and, some 
inflammatory markers, such as C-reactive protein (CRP) have received much attention since 
elevated serum CRP concentrations have been associated with CVD risk 
7,8
As a consequence, 
its use to predict CVD risk has been supported 
9
.  
Therefore, the aims of the present study in adolescents are 1) to examine how various body 
composition-screening tests relate to single and clustered CVD risk factors, 2) to examine 
how lean mass and BF (independently of each other) relate to clustered CVD risk factors and, 
3) to calculate specific thresholds for body composition indices associated with an unhealthier 
clustered CVD risk. 
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METHODS:  
Study design and study sample  
The current report is based on data derived from the Healthy Lifestyle in Europe by Nutrition 
in Adolescence cross-sectional study (HELENA-CSS). Participants were recruited at schools 
in 10 European cities: Stockholm (Sweden), Athens and Heraklion (Greece), Rome (Italy), 
Zaragoza (Spain), Pecs (Hungary), Ghent (Belgium), Lille (France), Dortmund (Germany) 
and Vienna (Austria). To ensure that the heterogeneity of social background of the population 
would be represented, schools were randomly selected after stratification by school zone or 
district. In cases where the selected schools refused to participate, a second list of substitute 
schools had already been drawn up. Up to three classes from two grades were selected per 
school. A class was considered eligible if the participation rate was at least 70%. Detailed 
descriptions of the HELENA sampling and recruitment approaches, standardization and 
harmonization processes, data collection, analysis strategies, quality control activities and 
inclusion criteria have been described in detail elsewhere 
10
. An extended and detailed manual 
of operations was designed for and thoroughly read by every researcher involved in the field 
work before data collection started.  
Data collection took place between October 2006 and December 2007 and the age range 
considered valid for the HELENA study was 12.5–17.49 years (n=3528). One-third of the 
school classes were randomly selected in each center for blood collection, resulting in a total 
of 1089 adolescents. However, valid data for CRP was only available in 748 adolescents. In 
order to make a better use of the data, sample sizes may vary depending on the outcome since 
the study samples did not differ in sex distribution, mean age and mean BMI from the whole 
HELENA sample (all p>0.05).  
The study was approved by the Research Ethics Committees of each city involved (for most 
this was the country’s ministry of health) and was performed following the ethical guidelines 
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of the Declaration of Helsinki, 1961 (revision of Edinburgh 2000) 
11
. We obtained written 
informed consent from the parents of the adolescents and the adolescents themselves. 
 
Blood pressure (BP) 
Systolic BP (SBP) has been consistently used as an individual CVD risk factor in youths 
12,13
. 
We measured SBP with an automatic oscillometric device (OMRON M6) which has been 
approved by the British Hypertension Society 
14
. The procedures to measure SBP have 
already been published
15
. Briefly, measurements were taken twice (10 min apart) and the 
lowest SBP value was retained.  
 
Cardiorespiratory fitness (CRF) 
Physical fitness characteristics of the study sample, as well as all the procedures used to 
assess physical fitness in the HELENA study, have already been published 
16
. CRF was 
assessed with the 20m shuttle run test (stage). A stage is the period of time in which the speed 
maintains constant. In this test, the initial speed is 8.5km
.
h
-1
, which is increased by 0.5km
.
h
-1 
.
min
-1
 (1 min equals one stage) 
17
. The equation reported by Léger et al. 
17
 was used to 
estimate the maximum oxygen consumption (VO2max, ml/kg/min). This test has been shown to 
be reliable in the HELENA adolescents (inter-trial difference -0.1 ± 1.5 stages in boys and 0.0 
± 1.1 stages in girls)
18
. We multiplied VO2max by -1 to indicate higher CVD risk with 
increasing value and be consistent with the other individual CVD risk factors. 
 
Biochemical measurements 
The blood sampling procedure and sample logistics have been previously described 
19
. We 
obtained venous blood samples after a 10-h overnight fast and we sent them to a central 
laboratory (the Analytical Laboratory at the University of Bonn’s Institut für Ernährungs- und 
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Lebensmittelwissenschaften). We measured serum concentrations of triglycerides, total 
cholesterol (TC), high-density lipoprotein cholesterol (HDLc), and glucose on the Dimension 
RxL clinical chemistry system (Dade Behring, Schwalbach, Germany) with enzymatic 
methods that used the manufacturer’s reagents and instructions. The TC/HDLc ratio was 
calculated. We measured insulin by a solid-phase two-site chemiluminescent immunometric 
assay with an Immulite 2000 analyzer (DPC Biermann GmbH, Bad Nauheim, Germany). We 
calculated insulin resistance (IR) through the homeostasis model assessment (HOMA-IR) 
index as: [insulin (mLU/mL) X glucose (mmol/L)] / 22.5 
20
. In addition, we measured high 
sensitive C-reactive protein by immunoturbidimetry (Olympus AU2700 Analyzer, Olympus 
UK Ltd., Watford, UK). 
 
CVD risk score 
We computed a composite CVD risk score following the one used by Andersen et al. 
12
, but 
excluding the sum of skinfolds (as this is one of the predictor variables) and including CRP. 
Briefly, we summed the age-and sex- specific Z scores of the individual risk factors (SBP, 
VO2max, HOMA-IR, CRP, TC/HDLc and triglycerides). We considered individuals with a 
CVD risk score higher than 1SD at risk and individuals with ≤1SD as having a healthier CVD 
risk score, as performed in previous studies 
12,21
.  
 
Anthropometry and body composition 
Harmonization and standardization of anthropometric measurements used to assess body 
composition were strictly controlled. Participants were barefoot and wearing underwear. 
Briefly, we measured body weight with an electronic scale (Type SECA 861; range, 0.05–130 
kg; precision, 0.05 kg). We measured height in the Frankfurt plane with a telescopic height 
measuring instrument (Type SECA 225; range, 60–200 cm; precision, 1 mm). Then, we 
calculated BMI as body weight (kg) divided by the height (m) squared. 
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We measured a set of skinfold thickness (biceps, triceps, subscapular, suprailiac, thigh, and 
calf) in triplicate on the left side of the body with a Holtain caliper (Crymmych, UK, range, 
0–40 mm; precision, 0.2 mm).  
We measured (in triplicate) WC at the midpoint between the lowest rib cage and the top of the 
iliac crest and hip circumference (HC) around the widest portion of the buttocks with a non-
elastic tape (Seca 200, MWS Ltd, Scalesmart) to the nearest 0.1 cm. 
We computed the sum of four skinfolds (biceps, triceps, subscapular and suprailiac), central-
peripheral skinfolds ratio (subscapular + suprailiac / biceps + triceps), waist-to-height ratio 
and (WHtR) and waist-to-hip ratio (WHR) from the original measurements.  
Lean body mass (kg) was obtained using a tetra-polar bioelectrical impedance device (BIA 
101 AKERN, Srl., Firenze, Italy) through the measurement of resistance and using the 
Bodygram Software V.1.41 (Akern S.r.l. Bioresearch, Pontassieve, Italy) for Windows. The 
following formulas were used to obtain lean mass from bioelectrical impedance analysis 
measurements
22
:  
Lean mass (kg) for males = −9.88 + 0.65 stature2/resistance + 0.26 weight + 0.02 resistance. 
Lean mass (kg) for females = −11.03 + 0.70 stature2/resistance + 0.17 weight + 0.02 resistance. 
 
Statistical analysis  
Descriptive data are shown as mean and standard deviation (SD) and were obtained by 
running analysis of variance (ANOVA) tests. We computed age- and sex-specific z-scores 
from our participants for all body composition indices included (height, BMI, lean mass, the 
sum of four skinfolds, central/peripheral skinfolds, WC, WHtR and WHR). We then divided 
the residual (actual minus predicted) value for each subject from the regression by its standard 
error to give a “studentized” residual. We performed linear regression models with single 
CVD risk factors (z-scores of SBP, VO2max, HOMA-IR index, CRP, TC/HDLc and 
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triglycerides) as dependent variables, and body composition indices (z-scores) as independent 
variables. In addition, we also performed linear regression models with the composite CVD 
risk score as dependent variable and the body composition indices as independent variables.  
It is known that BF and lean mass have a strong colinearity. Therefore, in order to analyze the 
association of the sum of four skinfolds (index of body fatness) independently of lean mass on 
CVD risk we performed a linear regression model of lean mass (independent variable) on 
CVD risk score (dependent variable) adjusting by the residuals of a previous regression of the 
sum of four skinfolds on lean mass. Similarly, to analyze the association of lean mass 
independently of the sum of four skinfolds on CVD risk we performed a linear regression 
model of the sum of four skinfolds (independent variable) on CVD risk score (dependent 
variable) adjusting by the residual of a previous regression of lean mass on the sum of four 
skinfolds 
23
. 
Finally, we performed Receiver Operating Characteristic (ROC) analyses curves for those 
body composition indices most associated with clustered CVD risk in both sexes. ROC curve 
provides the whole spectrum of specificity/sensitivity values for all the possible cut-offs. The 
area under the curve (AUC) is determined from plotting sensitivity versus 1-specifıcity of a 
test as the threshold varies over its entire range. Taking into account the suggested cut-off 
points, the test can be non-informative/ test equal to chance (AUC=0.5); less accurate 
(0.5<AUC≤0.7); moderately accurate (0.7<AUC≤0.9); highly accurate (0.9<AUC<1.0); and 
perfect discriminatory tests (AUC=1.0) 
24
. Cut-off points were selected for those scores 
optimizing the sensibility– specificity relationship. 
The statistical analyses were performed using the SPSS IBM statistics (version 21.0 for 
WINDOWS, Chicago, IL, USA), and the statistical software package Stata (version 12.0, 
Stata Corp., college Station, TX, USA). Alpha error was set at 5%. 
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RESULTS:  
Table 1 shows descriptive characteristics (mean ± SD) of the study sample. The ANOVA 
showed that there were no sex differences in age, BMI, WHtR ratio, HOMA-IR index score, 
TC/HDLc and CVD risk score; however, most variables differed by sex. 
 
Body composition and single CVD risk factors 
Table 2 shows that all body composition indices were positively associated with SBP (boys, 
adjusted R
2
 from 0.024 to 0.139 and girls, adjusted R
2
 from 0.008 to 0.11). In addition, all but 
height (in boys) were positively associated with VO2max (boys, adjusted R
2
 from 0.022 to 
0.173 and girls, adjusted R
2
 from 0.006 to 0.107). Note that VO2max was multiplied by -1 to 
indicate higher CVD risk with increasing value. Moreover, all body composition indices 
except height were positively associated with HOMA-IR index (boys, adjusted R
2
 from 0.014 
to 0.181 and girls, adjusted R
2
 from 0.034 to 0.102). Table 3 shows that all body composition 
indices except height were positively associated with TC/HDLc (boys, adjusted R
2
 from 0.007 
to 0.106 and girls, adjusted R
2
 from 0.015 to 0.078). In addition, all but height (both sexes) 
and the sum of four skinfolds (in girls) were positively associated with triglycerides (boys, 
adjusted R
2
 from 0.015 to 0.074 and girls, adjusted R
2
 from 0.011 to 0.022). Finally, and all 
but central/peripheral skinfolds (both sexes) and height (in girls) were positively associated 
with CRP (boys, adjusted R
2
 from 0.006 to 0.078 and girls, adjusted R
2
 from 0.007 to 0.045). 
 
Body composition and clustered CVD risk factors 
Table 4 shows that the top five body composition indices positively associated with clustered 
CVD risk were: the sum of four skinfolds, WHtR, BMI, WC and lean mass (adjusted R
2
 from 
0.182 to 0.523 in boys; adjusted R
2 
 from 0.167 to 0.388 in girls).  
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Table 5 shows that lean mass in girls (adjusted R
2
 = 0.569) was positively associated with 
clustered CVD risk independently of the sum of four skinfolds (used as an index of BF) while 
the sum of four skinfolds was positively associated with clustered CVD risk independently of 
lean mass (adjusted R
2
 = 0.729 and 0.785, boys and girls respectively). 
 
Body composition-related thresholds associated with an unhealthier clustered CVD risk 
Table 6 shows z-scores and specific thresholds for BMI, the sum of four skinfolds, WC, 
WHtR, and lean mass associated with an unhealthier clustered CVD risk in boys and girls 
(ROC curve analyses). In boys, highly accurate thresholds associated with an unhealthier 
clustered CVD risk were found for the sum of four skinfolds (≥68.5 mm; AUC=0.973), 
WHtR (≥0.46 cm; AUC=0.96), BMI (≥24.2 kg/m2; AUC=0.956) and WC (≥83.5 cm; 
AUC=0.951). In addition, this threshold was moderately accurate for lean mass (≥63.5 kg; 
AUC=0.822) (all p<0.001). In girls, moderately accurate thresholds associated with an 
unhealthier clustered CVD risk were found for the sum of four skinfolds (≥76 mm; 
AUC=0.819), WHtR (≥0.43 cm; AUC=0.854), BMI (≥24.3 kg/m2; AUC=0.816), WC (≥80.9 
cm; AUC=0.817) and lean mass (≥46.1 kg; AUC=0.773) (all p<0.001).  
 
DISCUSSION:  
The main findings of the present study indicate that: i) the majority of the assessed body 
composition indices are associated with single and clustered CVD risk in adolescents, ii) the 
sum of four skinfolds, BMI, WHtR, WC and lean mass are the strongest indices associated 
with clustered CVD risk, iii) lean mass, independently of the sum of four skinfolds (index of 
BF), is a significant contributing factor of clustered CVD risk in girls, iv) moderate to highly 
accurate specific thresholds for the sum of four skinfolds, BMI, WHtR, WC and lean mass are 
associated with an unhealthier clustered CVD risk in European adolescents. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
Gracia-Marco et al. 
 
14 
 
 
Body composition and single CVD risk factors 
In the present study, most body composition indices but specially BMI, WHtR, WC and the 
sum of four skinfolds are positively associated with the single CVD risk factors herein 
included. Controversial results have been published in this regard. Data in adolescent 
populations have shown that measurements of WC or fat mass are not stronger than BMI in 
identifying associations with CVD risk factors (i.e. SBP and diastolic BP, insulin, 
triglycerides fasting glucose, high low density lipoprotein cholesterol and low HDLc) 
25
. In 
this line, changes in age-specific BMI percentile from childhood to adulthood and pediatric 
metabolic syndrome were found to be predictors of CVD 
26
. Some studies have shown WC 
and WHR (but not BMI) to be linked to an increased risk of CVD mortality 
27
; whereas others 
have shown a similar association using BMI, WC, WHR and WHtR 
28
. In addition, both BMI 
and the sum of skinfold thicknesses have been shown to similarly identify children and 
adolescents at metabolic risk 
29
.  
 
Body composition and clustered CVD risk 
Our results show that the sum of four skinfolds, BMI, WHtR, WC and lean mass are the body 
composition indices more strongly associated with clustered CVD risk in boys and girls. The 
strength of the associations was quite similar among the body composition indices but it was 
higher in boys than girls. Our results agree with previous studies showing that measurements 
related to body circumferences (i.e. WC and WHR) were more related to clustered CVD risk 
than measurements related to body lengths (i.e. height). In this regard, height was not 
associated to clustered CVD risk in our study. WC, that reflects the amount of abdominal fat, 
has been shown as a good tool for the screening of metabolic syndrome in children 
30
. In 
addition, elevated skinfold thickness and WC measures in childhood have been found as the 
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strongest predictors of metabolic syndrome in early adulthood 
5
, suggesting tracking of 
adiposity status 
31
.  
It is known that there is collinearity between lean mass and BF and therefore, overweight and 
obese adolescents have more lean mass than their normoweight peers 
32
. The literature has 
consistently omitted the possibility that lean mass may be a significant contributing factor to 
clustered CVD risk independently of BF. In our study, we examined the association between 
lean mass and BF with clustered CVD risk after accounting for each other. On one hand, our 
results showed that the sum of 4 skinfolds (as an index of BF) was positively associated to 
clustered CVD risk in both sexes after accounting for lean mass. These findings support the 
notion of keeping BF to low levels to reduce the risk of CVDs. On the other hand and 
interestingly, lean mass was positively associated with clustered CVD risk in girls after 
accounting for BF while no association was found in boys, suggesting that lean mass might 
have a more protective factor for clustered CVD risk in boys than in girls. This positive 
association between lean mass and clustered CVD risk helps to explain why an index such as 
BMI (which includes both fat and lean mass) has been widely related to CVD risk, in spite of 
the surrounding controversy about its use as an index of adiposity. A possible physiological 
approach to this positive association may be related to the fact that a higher lean mass leads to 
a higher circulating blood volume, increasing the left ventricular (LV) stroke volume and, as a 
consequence, cardiac output. Previous studies have shown that lean mass explains a much 
larger proportion of the variance of cardiac output (33% vs. 3%) and stroke volume (49% vs. 
2%) than does fat mass 
33
, which relates to the fact that lean mass is a tissue with much higher 
metabolic demand than BF 
34
. As a consequence of these changes, there may be LV 
alterations that may lead to LV hypertrophy 
35
,  a condition whose risk is increased in 
individuals with an excess of body weight and women, which may also explain our sex 
differences. This finding is of importance to pediatric research since age-related increases in 
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body size during youth mainly reflect increases in lean mass rather than BF 
36,37
. In this line, 
Brion et al. 
6
 found a positive association between blood pressure (a single CVD risk factor) 
and lean mass after accounting for BF. To the best of our knowledge, this is the first study 
that shows this association convincingly and using a large sample. However, future studies 
with a longitudinal design are needed to confirm our findings. 
 
Body composition-related thresholds and unhealthier clustered CVD risk  
BMI, WHtR and WC are all body composition indices that include lean mass and have been 
used worldwide in epidemiologic studies. In the present study, the sum of four skinfolds, 
BMI, WHtR, WC and lean mass showed strong and positive associations with clustered CVD 
risk (that includes inflammation). Moderate to highly accurate thresholds in boys (all AUCs > 
0.822) and moderately accurate thresholds in girls (all AUCs > 0.773) associated with an 
unhealthier clustered CVD risk were found. Interestingly, our BMI threshold (24.2 and 24.3 
kg/m
2
, boys and girls respectively) is very similar to the one provided by Cole et al. for 15 yr 
old overweight boys and girls (23.3 and 23.9 kg/m
2
) 
38
. In our study, the mean age of the 
participants was 14.8 yr. Cole et al. reported BMI values for 15 yr old obese boys and girls of 
28.3 and 29.1 kg/m
2
 respectively, which are much higher than our BMI thresholds. This 
comparison suggests that slightly overweight adolescents already have an unhealthier 
clustered CVD risk. Neovius et al. 
39
 in their study with adolescents aged 17 years observed 
that the BMI, percentage body fat and WC weakly identified individual CVD risk factors (i.e. 
adverse insulin and lipid profile). However, the use of a cluster was more accurate (AUCs 
0.76-0.91). Freedman et al. 
40
 in their study with children aged 5-17 years observed a similar 
prediction of clustered CVD risk between BMIz and WHtR (AUCs 0.85 and 0.86, 
respectively). Sardinha et al. 
41
 in their study with children and adolescents aged 10-15 years 
observed that BMI and triceps skinfold thickness accurately predicted obesity (AUCs ranged 
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from 0.89 to 0.96 for girls and 0.61 to 0.98 for boys). Similarly, Sarria et al. 
42
 in their study 
with children and adolescents aged 7-16.9 years observed that triceps skinfold, BMI and WC 
accurately predicted adiposity (AUCs 0.90, 0.88 and 0.86, respectively).  
The validity of BMI as a measure of BF has been extensively questioned. Freedman et al. 
43
 
observed that a high BMI-for-age was associated with a moderately high (70-80%) sensitivity 
and positive predictive value, along with a high specificity (95%) in identifying an excess of 
BF in children. In Chinese adolescents, Ng et al. obtained BMI and WC thresholds that 
predict clustered CVD risk, obtaining similar AUCs than ours in girls (0.85 and 0.82, 
respectively) but lower AUCs in boys (0.76 and 0.78, respectively) 
44
. Differences between 
studies may be due to methodological differences in data collection or even in data 
preparation (i.e. use of z-scores). In addition, our CVD risk score includes CRP 
9
, which may 
strengthen the associations.  
 
Limitations and strengths 
The main limitation of this study is its cross-sectional design that precludes determining any 
causality in the findings. The present study has, however, several strengths: the main one is 
the thorough standardization of the methods and collection of data throughout all the cities 
involved. In addition, a large number of body composition indices (including lean mass) as 
well as CVD risk factors (including an inflammatory marker such as CRP) have been 
considered.  
 
CONCLUSIONS 
Our results support an association between most of the assessed body composition indices and 
single and clustered CVD risk factors in European adolescents. In addition, lean mass is 
positively associated with clustered CVD risk independently of BF in girls, which is a novel 
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finding. Finally, moderate to highly accurate specific thresholds associated with an 
unhealthier clustered CVD risk are provided for the sum of four skinfolds, WHtR, BMI, WC 
and lean mass in boys and girls.  
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Table 1. Descriptive characteristics of the population sample. 
  
Whole group  Boys  Girls 
P n=1089  n=509  n=580 
  Mean SD  Mean SD  Mean SD 
Age (years) 14.8 1.2  14.8 1.2  14.8 1.2 .66 
Weight (kg) 58.7 12.7  62 14.3  55.9 10.2 < .001 
Height (cm) 165.4 9.3  169.6 9.9  161.7 7 < .001 
BMI (kg/m
2
) 21.4 3.7  21.4 4  21.3 3.4 .61 
Lean mass (kg) 46.2 8.6  51.7 9  41.5 4.6 < .001 
Sum of four skinfolds (mm) 
a
 51.9 26.2  44.3 27.2  58.6 23.5 < .001 
Central / peripheral skinfolds (mm) 
 b
 0.3 0.2  0.3 0.2  0.2 0.1 < .001 
WC (cm) 72.4 8.6  74.4 9.1  70.7 7.8 < .001 
HC (cm) 91.7 8.7  90.4 9  92.8 8.3 < .001 
WHtR (cm) 0.4 0.1  0.4 0.1  0.4 0.1 .51 
WHR (cm) 0.8 0.1  0.8 0.1  0.8 0.1 < .001 
SBP (mm Hg) 116.2 13.3  120.5 13.8  112.5 11.6 < .001 
VO2 max (ml/kg/min) 42.3 10.9  44.4 7.9  36.4 5.5 < .001 
HOMA-IR index 2.3 1.9  2.4 2.2  2.3 1.6 .68 
TC/HDL-c (mg/dL) 3 0.7  3 0.7  3 0.6 .61 
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Triglycerides (mg/dL) 69.1 35  64.4 31.8  73.3 37.1 < .001 
CRP (mg/L) (n=748) 1.1 3.9  1.6 5.4  0.9 1.7 0.07 
Cardiovascular risk score 0.01 0.56  -0.15 4.12  0.23 3.74 .19 
 
Results shown as mean ± SD (standard deviation) 
a 
Sum of: biceps, triceps, subscapular, suprailiac  
b
 (subscapular + suprailiac) / (biceps + triceps)  
Sex differences (ANOVA) are shown in bold (p < 0.05) 
BMI (body mass index), CRP (C-reactive protein), HC (hip circumference), HOMA-IR (homeostasis model assessment-insulin resistance), SBP (systolic blood pressure), 
TC/HDL-c (total cholesterol/ high-density lipoprotein cholesterol), VO2 max (maximal oxygen consumption), WC (waist circumference), WHR (waist-to-hip ratio), WHtR 
(waist-to-height ratio)  
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Table 2. Linear regression analyses of systolic blood pressure, maximal oxygen consumption and 
HOMA-IR index as regards to body composition indices in European adolescents. 
  Boys  G irls 
  Adjusted R
2
 β SE P  Adjusted R2 β SE P 
Indep. variables SBP (z) 
a
 (n=1089) 
Height (z) 0.037 0.193 0.98 < .001  0.008 0.094 0.99 < .001 
BMI (z) 0.139 0.375 0.93 < .001  0.11 0.333 0.94 < .001 
Lean mass (z) 0.161 0.436 0.92 < .001  0.105 0.49 0.94 < .001 
Sum of four skinfolds (z) 
b
 0.053 0.235 0.97 < .001  0.033 0.184 0.98 < .001 
C/P skinfolds (z) 
 c
 0.026 0.163 0.98 < .001  0.004 0.07 0.99 .003 
WC (z) 0.121 0.35 0.94 < .001  0.092 0.303 0.95 < .001 
WHtR (z) 0.077 0.28 0.96 < .001  0.068 0.259 0.96 < .001 
WHR (z) 0.024 0.157 0.99 < .001  0.013 0.117 0.98 < .001 
  VO2 max (z) 
a
 (n=1089) 
Height (z) 0.002 -0.049 0.99 .07  0.006 -0.08 0.99 .002 
BMI (z) 0.173 0.419 0.91 < .001  0.107 0.338 0.94 < .001 
Lean mass (z) 0.046 0.239 0.98 < .001  0.019 0.206 0.99 < .001 
Sum of four skinfolds (z) 
b
 0.156 0.396 0.92 < .001  0.106 0.329 0.94 < .001 
C/P skinfolds (z) 
 c
 0.022 0.149 0.99 < .001  0.02 0.145 0.99 < .001 
WC (z) 0.143 0.385 0.93 < .001  0.069 0.264 0.97 < .001 
WHtR (z) 0.161 0.408 0.92 < .001  0.084 0.297 0.96 < .001 
WHR (z) 0.049 0.222 0.98 < .001  0.006 0.083 0.99 .001 
 HOMA-IR index (z) 
a
 (n=1089) 
Height (z) 0.004 0.077 0.99 .08  -0.002 0.009 0.99 .83 
BMI (z) 0.181 0.437 0.9 < .001  0.089 0.315 0.95 < .001 
Lean mass (z) 0.112 0.363 0.94 < .001  0.046 0.333 0.98 < .001 
Sum of four skinfolds (z) 
b
 0.136 0.364 0.93 < .001  0.079 0.296 0.96 < .001 
C/P skinfolds (z) 
 c
 0.016 0.049 0.99 < .001  0.047 0.22 0.98 < .001 
WC (z) 0.149 0.407 0.92 < .001  0.102 0.324 0.95 < .001 
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WHtR (z) 0.131 0.384 0.93 < .001  0.094 0.315 0.95 < .001 
WHR (z) 0.014 0.135 0.99 .005  0.034 0.173 0.99 < .001 
 
Significant results are in bold.  
β is the estimated standardized regression coefficient; SE, standard error. 
a
 It was entered as dependent variable and each independent variable (i.e. z-scores of height, BMI, lean mass, 
sum of four skinfolds, central-peripheral skinfolds, WC, WHtR and WHR) were entered separately in different 
models. 
b 
Sum of: biceps, triceps, subscapular, suprailiac  
c
 Central / peripheral skinfolds ratio: (subscapular + suprailiac) / (biceps + triceps) 
BMI (body mass index), HC (hip circumference), HOMA-IR (homeostasis model assessment-insulin resistance), 
SBP (systolic blood pressure), VO2 max (maximal oxygen consumption), WC (waist circumference), WHR (waist-
to-hip ratio), WHtR (waist-to-height ratio)  
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Table 3. Linear regression analyses of total cholesterol/ high-density lipoprotein cholesterol, 
triglycerides and C-reactive protein as regards to body composition indices in European 
adolescents. 
  Boys  G irls 
  Adjusted R
2
 β SE P  Adjusted R2 β SE P 
Indep. variables TC/HDLc (z)
  a
 (n=1089) 
Height (z) <0.001 -0.047 0.99 .23  0.003 -0.069 0.99 .09 
BMI (z) 0.106 0.323 0.94 < .001  0.068 0.274 0.96 < .001 
Lean mass (z) 0.031 0.192 0.97 < .001  0.015 0.192 0.98 .002 
Sum of four skinfolds (z) 
b
 0.053 0.229 0.97 < .001  0.046 0.227 0.97 < .001 
C/P skinfolds (z) 
 c
 0.007 0.082 0.96 .04  0.026 0.165 0.98 < .001 
WC (z) 0.079 0.29 0.93 < .001  0.066 0.259 0.96 < .001 
WHtR (z) 0.091 0.311 0.92 < .001  0.078 0.284 0.95 < .001 
WHR (z) 0.021 0.158 0.96 .001  0.03 0.162 0.98 < .001 
  Triglycerides (z) 
a
 (n=1089) 
Height (z) -0.002 -0.012 0.99 .78  -0.002 0.015 0.99 .72 
BMI (z) 0.072 0.267 0.96 < .001  0.014 0.132 0.99 .002 
Lean mass (z) 0.03 0.188 0.97 < .001  0.016 0.199 0.99 .002 
Sum of four skinfolds (z) 
b
 0.044 0.209 0.97 < .001  0.001 0.05 0.99 .25 
C/P skinfolds (z) 
 c
 0.016 0.119 0.97 .003  0.021 0.149 0.99 < .001 
WC (z) 0.071 `0.279 0.94 < .001  0.022 0.153 0.99 < .001 
WHtR (z) 0.074 0.286 0.94 < .001  0.018 0.143 0.99 .001 
WHR (z) 0.015 0.137 0.97 .003  0.011 0.104 0.99 .008 
 CRP (z)  
a
 (n=748) 
Height (z) 0.006 -0.087 0.99 .05  0.001 -0.039 1 .35 
BMI (z) 0.074 0.276 0.96 < .001  0.045 0.231 0.98 < .001 
Lean mass (z) 0.008 0.107 0.99 0.03  0.013 0.183 0.99 0.005 
Sum of four skinfolds (z) 
b
 0.062 0.251 0.97 < .001  0.045 0.23 0.98 < .001 
C/P skinfolds (z) 
 c
 -0.001 0.031 1 .48  -0.002 -0.018 1 .67 
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WC (z) 0.059 0.26 0.97 < .001  0.033 0.19 0.98 < .001 
WHtR (z) 0.078 0.302 0.96 < .001  0.039 0.21 0.98 < .001 
WHR (z) 0.049 0.247 0.97 < .001  0.007 0.095 0.99 .04 
 
Significant results are in bold.  
β is the estimated standardized regression coefficient; SE, standard error. 
a
 It was entered as dependent variable and each independent variable (i.e. z-scores of height, BMI, lean mass, 
sum of four skinfolds, central-peripheral skinfolds, WC, WHtR and WHR) were entered separately in different 
models. 
b 
Sum of: biceps, triceps, subscapular, suprailiac  
c
 Central / peripheral skinfolds ratio: (subscapular + suprailiac) / (biceps + triceps) 
BMI (body mass index), CRP (C-reactive protein), HC (hip circumference), TC/HDL-c (total cholesterol/ high-
density lipoprotein cholesterol), WC (waist circumference), WHR (waist-to-hip ratio), WHtR (waist-to-height 
ratio)  
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Table 4. Linear regression analyses of the cardiovascular risk score [sum of SBP(z), VO2max 
(z), HOMA-IR index (z), CRP (z), TC/HDLc (z) and triglycerides (z)] as regards to body 
composition indices in European adolescents.  
 
  Boys  G irls 
  Adjusted R
2
 β SE P  Adjusted R2 β SE P 
 Cardiovascular risk score 
a 
(n=748) 
Height (z) -0.003 -0.038 4.12 .86  -0.002 0.1 3.74 .58 
BMI (z) 0.523 3.122 2.84 < .001  0.388 2.468 2.93 < .001 
Lean mass (z) 0.182 1.947 3.7 < .001  0.167 2.262 3.42 < .001 
Sum of four skinfolds (z) 
b
 0.589 3.15 2.64 < .001  0.405 2.596 2.88 < .001 
C/P skinfolds (z) 
 c
 0.025 0.669 4.06 .001  0.072 0.984 3.6 < .001 
WC (z) 0.47 3.009 2.99 < .001  0.348 2.166 3.02 < .001 
WHtR (z) 0.497 3.138 2.92 < .001  0.339 2.208 3.04 < .001 
WHR (z) 0.158 1.795 3.78 < .001  0.118 1.268 3.5 < .001 
 
Significant results are in bold.  
β is the estimated standardized regression coefficient; SE, standard error. 
a
 It was entered as dependent variable and each independent variable (i.e. z-scores of height, BMI, lean mass, 
sum of four skinfolds, central-peripheral skinfolds, WC, WHtR and WHR) were entered separately in different 
models. 
b 
Sum of: biceps, triceps, subscapular, suprailiac  
c
 Central / peripheral skinfolds ratio: (subscapular + suprailiac) / (biceps + triceps) 
BMI (body mass index), HC (hip circumference), TC/HDL-c (total cholesterol/ high-density lipoprotein 
cholesterol), WC (waist circumference), WHR (waist-to-hip ratio), WHtR (waist-to-height ratio)  
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Table 5. Linear regression analyses of cardiovascular risk score [sum of SBP(z), VO2max (z), 
HOMA-IR index (z), CRP (z), TC/HDLc (z) and triglycerides (z)] in European adolescents 
participating in the HELENA study as regards to lean mass and sum of 4 skinfolds. 
 Boys  G irls 
 Adjusted R
2
 β SE P  Adjusted R2 β SE P 
Independent variables Cardiovascular risk score 
a 
(n=748) 
Lean mass (z) 0.336 0.061 0. 013 .65  0.569 0.378 0.015 .02 
Sum of four skinfolds (z) 
 b
 0.729 1.366 0.013 < .001  0.785 0.346 0. 011 < .001 
 
Significant results are in bold 
β is the estimated standardized regression coefficient; SE, standard error 
CRP (C-reactive protein), HOMA-IR (homeostasis model assessment-insulin resistance), SBP (systolic blood 
pressure), TC/HDL-c (total cholesterol/ high-density lipoprotein cholesterol), VO2 max (maximal oxygen 
consumption) 
a
 These analyses were adjusted by the residuals of the regression between lean and sum 4 skinfolds 
b 
Sum of: biceps, triceps, subscapular, suprailiac  
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Table 6. Body composition indices-related thresholds associated with an unhealthier clustered 
CVD risk in European adolescents participating in the HELENA study 
 
a
 Z-score represents a specific threshold for having or not clustered CVD risk (all p< .001) 
b
 The threshold below which adolescents present a healthier clustered CVD risk. This threshold was obtained 
using the equation: z = (value-mean) / SD 
c 
Sum of: biceps, triceps, subscapular, suprailiac  
AUC (Area Under the Curve), CI (Confidence Intervals), Sens (sensitivity), Spec (specificity) 
 BOYS (n=365)  GIRLS (n=383) 
Body composition 
indices 
z-score
a
 Threshold
b
 AUC 95% CI Sens. Spec.  z-score
a
 Threshold
b
 AUC 95% CI Sens. Spec. 
Body mass index 0.795 24.2 0.956 0.923-0.989 0.913 0.904  0.937 24.3 0.816 0.656-0.973 0.769 0.878 
Sum of four skinfolds 
c
 0.852 68.5 0.973 0.956-0.989 1.000 0.880  0.764 76.0 0.819 0.7-0.938 0.769 0.792 
Waist circumference 1.057 83.5 0.951 0.91-0.992 0.913 0.915  1.340 80.9 0.817 0.665-0.97 0.692 0.924 
Waist-to-height ratio 0.474 0.46 0.960 0.933- 0.987 0.955 0.860  0.467 0.43 0.854 0.702-0.949 0.750 0.819 
Lean mass 1.365 63.5 0.822 0.717– 0.927 0.727 0.909  1.034 46.1 0.773 0.594- 0.953 0.692 0.900 
